Affiliation:
1. Institute of Genetic Engineering and Biotechnology for Post Graduate Studies, University of Baghdad, Iraq.
Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central
nervous system (CNS) caused by auto-reactive T cells against
myelin antigens. T-cell immunoglobulin mucin -3 (TIM-3) is a
negative regulator glycoprotein expressed by a range of immune
cells. A defect in TIM-3 regulation has been shown in multiple
sclerosis patients. This study was planned to investigate the
correlation between serum TIM-3 and TIM-3 gene expression in
a sample of Multiple Sclerosis Iraqi patients. Three ml of blood
samples were collected from fifty Iraqi patients who have
Multiple Sclerosis (men and women) with ages ranging between
20-57 years, and 50 healthy volunteers as a control group;
0.25ml of blood was put in Trizol tube for RNA extraction,
subsequently to estimate TIM-3 gene expression by one step
RT-qPCR, and 2.75 ml of blood placed into gel tube for
determination TIM-3 serum level by enzyme-linked
immunosorbent assay (ELISA), the Statistical analysis was done
by using program of Statistical Analysis System (SAS). There
was a significant increase (P ≤ 0.05) in TIM-3 gene expression
for patients (5.30-fold) when compared with control (7.86-fold).
Moreover, the result demonstrated a high significant elevated (P
≤ 0.01) in TIM-3 serum level of patients (0.398 pg/ml) as
compared to control (3.17 pg/ml. Furthermore, the findings
showed a strong positive association between TIM-3 serum
level and TIM-3 mRNA expression with significant differences.
The current study concluded that the TIM-3 gene expression and
TIM-3 serum level were high in MS patients, and there was a
direct positive relationship between TIM-3 gene expression and
TIM-3 serum level.
Keywords: MS, TIM-3, RT-qPCR.,ELISA
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference79 articles.
1. 1. Thompson, A.J.; Banwell, B.L.; Barkhof, F.; Carroll, W.M.; Coetzee, T.; Comi, G.;
2. Correale, J.; Fazekas, F.; Filippi, M.; Freedman, M.S.; et al.Diagnosis of multiple
3. sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol., 2018; 17, 162–
4. 173.
5. 2. Dendrou, C.A.; Fugger, L.; Friese, M.AImmunopathology of multiple sclerosis.